Supporting Patients with TDT Learn More About Transfusion-Dependent Beta-Thalassemia (TDT) With These Multimedia Resources

Provider and Patient Resources

Download these resources to learn more about chronic transfusion and chelation therapy, the benefits and risks associated with HSCT, and the impact of these treatments on patients' quality of life.

Provider Resources

Challenge TDT Guide

An overview of TDT, transfusion therapy, HSCT, and quality of life and more.

Transfusion-Dependent Beta-Thalassemia (TDT) Is A Severe Genetic Disease That Impacts Patients for Life

This PDF summarizes the main characteristics of TDT, the complications and limitations of red blood cell transfusions, and available TDT treatment options.

Transfusion Therapy: Chronic RBC Transfusions are Central to the Treatment of TDT

This PDF summarizes transfusion therapy guidelines, the benefits and complications of chronic transfusions, and risks like comorbidities and early mortality.

Allogeneic HSCT Is a Treatment Option with the Potential to Correct the Genetic Deficiency of Beta-Thalassemia

This PDF summarizes the benefits and risks of allogeneic HSCT and the kinds of TDT patients it might be suitable for.

Transfusion-Dependent Beta-Thalassemia (TDT) Significantly Affects Quality of Life

This PDF summarizes the effects of treatment on quality of life and comparison of quality of life and overall survival in conventional therapy versus HSCT.

Patient Resources

Help patients better understand the current impact TDT has on their lives, set goals, and plan for the future.

Visit LifeWithBetaThal.com

Understanding Beta‑Thalassemia Brochure

A quick, takeaway guide to help patients better understand the genetic basis of their beta-thalassemia.

Professional Organizations

Here are some professional organizations with helpful resources and information about beta-thalassemia, transfusion and chelation therapy, allogeneic HSCT, and the impact of TDT on patients' lives.

bluebird bio, Inc. is not responsible for the content provided by third party sites, nor does bluebird bio, Inc. endorse the content of these sites. Above is not a comprehensive list of resources and it is provided for reference only.

bluebird bio, Inc. is not responsible for the content provided by third party sites, nor does bluebird bio, Inc. endorse the content of these sites. Below is not a comprehensive list of resources and it is provided for reference only.

Beta-Thalassemia and TDT

Find information about long-term survival rates of TDT patients treated with hematopoietic stem cell transplantation and analysis stressing the importance of long-term follow-up after hematopoietic stem cell transplantation.

Treatment Guidelines

Find guidelines for the standard monitoring of patients with thalassemia, how chronic transfusion therapy extends life expectancy, and complications of therapy.

Allogeneic HSCT

Learn more about hematopoietic stem cell transplantation in thalassemia, effects on patient quality of life, managing iron overload and sickle cell anemia.